Motomu Tsuji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Motomu Tsuji has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Ayami Takayama
Department of Internal Medicine (I), Osaka Medical College, 2-7 Daigakumachi, Takatsuki City, Osaka, 569-0801, Japan
2 shared publications - Kazuki Iwaki
Department of Internal Medicine (I), Osaka Medical College, 2-7 Daigakumachi, Takatsuki City, Osaka, 569-0801, Japan
2 shared publications - Shoko Nakayama
Department of Internal Medicine (I), Osaka Medical College, Takatsuki City, Osaka, Japan
2 shared publications - Taiji Yokote
Department of Internal Medicine (I), Osaka Medical College, 2-7 Daigakumachi, Takatsuki City, Osaka, 569-0801, Japan
2 shared publications - Takuji Miyoshi
Department of Internal Medicine (I), Osaka Medical College, 2-7 Daigakumachi, Takatsuki City, Osaka, 569-0801, Japan
2 shared publications - Toshiaki Hanafusa
Osaka Medical College
2 shared publications
Latest Publications
- Open Access
- 21 November 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 538
A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant
Clear cell sarcoma (CCS) and malignant melanoma share overlapping immunohistochemistry with regard to the melanocytic markers HMB45, S100, and Melan-A. However, the translocation t(12; 22)(q13; q12) is specific to CCS. Therefore, although these neoplasms are closely related, they are now considered to be distinct entities. However, the translocation is apparently detectable only in 50%–70% of CCS cases. Therefore, the absence of a detectable EWS/AFT1 rearrangement may occasionally lead to erroneous exclusion of a translocation-negative CCS. Therefore, histological assessment is essential for the correct diagnosis of CCS. Primary CCS of the bone is exceedingly rare. Only a few cases of primary CCS arising in the ulna, metatarsals, ribs, radius, sacrum, and humerus have been reported, and primary CCS arising in the pubic bone has not been reported till date.
- 21 November 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 538
Open AccessA rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant
Clear cell sarcoma (CCS) and malignant melanoma share overlapping immunohistochemistry with regard to the melanocytic markers HMB45, S100, and Melan-A. However, the translocation t(12; 22)(q13; q12) is specific to CCS. Therefore, although these neoplasms are closely related, they are now considered to be distinct entities. However, the translocation is apparently detectable only in 50%–70% of CCS cases. Therefore, the absence of a detectable EWS/AFT1 rearrangement may occasionally lead to erroneous exclusion of a translocation-negative CCS. Therefore, histological assessment is essential for the correct diagnosis of CCS. Primary CCS of the bone is exceedingly rare. Only a few cases of primary CCS arising in the ulna, metatarsals, ribs, radius, sacrum, and humerus have been reported, and primary CCS arising in the pubic bone has not been reported till date.
- Open Access
- 28 September 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 131
An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138+ cells
World Health Organization (WHO) criteria are commonly used to diagnose plasma cell myeloma (PCM); however, these criteria are complex and require several laboratory parameters. For differentiating reactive plasmacytosis from clonal plasma cell (PC) neoplasms such as PCM, it is important to accurately determine the expression of cytoplasmic immunoglobulin light chains.
- 28 September 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 131
Open AccessAn approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138+ cells
World Health Organization (WHO) criteria are commonly used to diagnose plasma cell myeloma (PCM); however, these criteria are complex and require several laboratory parameters. For differentiating reactive plasmacytosis from clonal plasma cell (PC) neoplasms such as PCM, it is important to accurately determine the expression of cytoplasmic immunoglobulin light chains.
- 1 January 2002
- Published by Elsevier in Pathology - Research and Practice
- Vol. 198 (7) , 501-505
Epithelioid Hemangioendothelioma with Osteoclast-like Giant Cells
- 1 January 2002
- Published by Elsevier in Pathology - Research and Practice
- Vol. 198 (7) , 501-505
Epithelioid Hemangioendothelioma with Osteoclast-like Giant Cells
- 1 January 2000
- Published by Wiley in Pathology International
- Vol. 50 (1) , 41-47
Primary hepatic leiomyosarcoma in a patient with hepatitis C virus‐related liver cirrhosis
We describe an autopsy case of primary hepatic leiomyosarcoma in a 68‐year‐old man with hepatitis C virus‐related liver cirrhosis. The patient, who had a history of acute hepatitis 20 years previously, died of a ruptured hepatic tumor. At autopsy, a well‐circumscribed 14 × 16 × 15 cm tumor replaced the medial site of the right hepatic lobe with multiple intrahepatic and distant metastases. Histologically the tumor, which had extensive central necrosis, consisted predominantly of well or moderately differentiated spindle‐shaped cells, which were positive for smooth muscle actin and vimentin on immunohistochemical staining. In addition, clusters of markedly atypical cells and myxoid change of the matrix were discretely found in the focal and small areas of the tumor. These findings indicated that many sections were necessary for the histologically accurate estimation of primary hepatic smooth muscle tumor. The histological examination of a non‐tumorous lesion showed liver cirrhosis. Hepatitis C virus was detected in the cytoplasm of cirrhotic hepatocytes by immunohistochemistry and reverse transcriptase–polymerase chain reaction, but not in the tumor cells. This suggested that the virus was not directly involved in the development of primary hepatic leiomyosarcoma.
- 1 January 2000
- Published by Wiley in Pathology International
- Vol. 50 (1) , 41-47
Primary hepatic leiomyosarcoma in a patient with hepatitis C virus‐related liver cirrhosis
We describe an autopsy case of primary hepatic leiomyosarcoma in a 68‐year‐old man with hepatitis C virus‐related liver cirrhosis. The patient, who had a history of acute hepatitis 20 years previously, died of a ruptured hepatic tumor. At autopsy, a well‐circumscribed 14 × 16 × 15 cm tumor replaced the medial site of the right hepatic lobe with multiple intrahepatic and distant metastases. Histologically the tumor, which had extensive central necrosis, consisted predominantly of well or moderately differentiated spindle‐shaped cells, which were positive for smooth muscle actin and vimentin on immunohistochemical staining. In addition, clusters of markedly atypical cells and myxoid change of the matrix were discretely found in the focal and small areas of the tumor. These findings indicated that many sections were necessary for the histologically accurate estimation of primary hepatic smooth muscle tumor. The histological examination of a non‐tumorous lesion showed liver cirrhosis. Hepatitis C virus was detected in the cytoplasm of cirrhotic hepatocytes by immunohistochemistry and reverse transcriptase–polymerase chain reaction, but not in the tumor cells. This suggested that the virus was not directly involved in the development of primary hepatic leiomyosarcoma.